학술논문
Population-Based Characterization of the Pharmacokinetics and Food Effect of ANAVEX3-71, a Novel Sigma-1 Receptor and Allosteric M1 Muscarinic Receptor Agonist in Development for Treatment of Frontotemporal Dementia, Schizophrenia, and Alzheimer Disease
Document Type
Article
Author
Source
In: Clinical Pharmacology in Drug Development . (Clinical Pharmacology in Drug Development, January 2024, 13(1):21-31)
Subject
Language
English
ISSN
21607648
2160763X
2160763X